查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827777

2025年RNA分析與轉錄組學全球市場報告

RNA Analysis/ Transcriptomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，RNA分析和轉錄組學市場快速擴張，從2024年的77.2億美元成長到2025年的87.4億美元，複合年成長率為13.3%。預測期內的成長歸因於癌症研究和精準醫療、藥物研發、感染疾病診斷、個人化醫療、學術和政府資助以及農業領域不斷擴展的應用。

預計未來幾年 RNA 分析和轉錄組學市場將快速成長，到 2029 年將達到 163.1 億美元，年複合成長率(CAGR)為 16.9%。預測期內的成長歸因於單細胞 RNA 定序應用、RNA 分析在臨床診斷中的整合、基於 RNA 的治療方法和疫苗、生物資訊學和數據分析工具以及生物標記的發現和檢驗。預測期內的主要趨勢包括空間轉錄組學和原位 RNA 分析、長讀 RNA 定序技術、RNA 編輯和修飾分析、人工智慧在 RNA 數據分析中的整合、罕見疾病的 RNA 治療方法以及用於癌症檢測的基於 RNA 的液態切片。

轉錄組學，也稱為 RNA 分析，是在特定背景、環境條件或特定細胞內使用複雜方法對轉錄組進行研究。

RNA分析和轉錄組學市場的主要產品類型包括試劑/耗材、儀器和軟體。這些產品應用於臨床診斷、藥物研發、毒理基因體學、比較轉錄組學和RNA干擾等多個領域。 RNA分析和轉錄組學涉及的關鍵技術包括微陣列、定序、聚合酵素鏈鎖反應和RNA干擾。在臨床診斷中，RNA分析用於檢測不同種類的RNA、病原體RNA、剪接變異體以及其他疾病診斷所需的元素。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 RNA 分析和轉錄組學市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的 RNA 分析和轉錄組學細分市場、市場趨勢和機遇，以及您在 RNA 分析和轉錄組學行業取得成功所需的數據。這份 RNA 分析和轉錄組學市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長16.9%，較先前預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這種影響將透過對主要來自瑞士和新加坡的逆轉錄酶和次世代定序儀流動槽徵收關稅直接影響美國，從而提高基因組研究和診斷的成本。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

RNA分析和轉錄組學市場的成長預計將受到個人化醫療需求日益成長的推動，個人化醫療是指根據每位患者的個別特徵量身定做治療方案。 RNA定序技術非常適合管理與實施個人化醫療實踐和流程相關的龐大臨床工作量。個人化醫療聯盟 (PMC) 於2022年10月報告稱，將有超過75,000種基因檢測產品和超過300種個人化藥物可用於治療各種疾病，包括多種癌症、罕見遺傳疾病以及慢性病和感染疾病。個人化藥物需求的激增是推動RNA分析市場成長的關鍵因素。

慢性病的日益普及預計將推動未來 RNA 分析和轉錄組學市場的擴張。慢性病是一種持續時間超過一年、干擾日常生活並需要持續醫療照護的疾病。在慢性病研究中使用 RNA 分析和轉錄組學可以加深對疾病機制的理解，從而實現更好的診斷並促進開發更有針對性和個性化的治療性介入。例如，2022 年 9 月，總部位於瑞士的聯合國專門機構世界衛生組織 (WHO) 報告稱，非傳染性疾病 (NCD) 或慢性病每年在全球造成 4,100 萬人死亡，佔所有死亡人數的 74%。其中，心血管疾病造成 1,790 萬人死亡，癌症造成 930 萬人死亡，慢性呼吸道疾病造成 410 萬人死亡，糖尿病造成 200 萬人死亡。因此，慢性病盛行率的上升正在推動 RNA 分析和轉錄組學市場的成長。

RNA分析和轉錄組學市場的一個新興趨勢是關注RNA分析的技術進步和創新。次世代定序儀（NGS）和RNA干擾（RNAi）等技術有助於提高轉錄活性分析的精確度和準確性。例如，Illumina開發的次世代定序儀成功地分割了DNA/RNA，創建了定序文庫並組裝進行了重組，從而增強了基因組序列分析。

RNA分析和轉錄組學市場的主要企業越來越注重推出創新產品組合，以獲得競爭優勢。 2023年5月，Twist Bioscience Corporation宣布推出一套全面的RNA定序工具，包括針對RNA和全轉錄組定序的標靶富集功能。此組合包含Twist RNA外顯子組、Twist RNA文庫製備試劑盒以及Twist核醣體RNA (rRNA)和血紅蛋白(Globin)去除試劑盒等產品，描述了分析mRNA蛋白編碼序列、客製化標靶和總RNA的完整工作流程。

策略夥伴關係和合作是RNA分析和轉錄組學市場主要企業關注的重點。此類合作通常涉及整合RNA文庫製備試劑套件的專業知識，並整合不同機構的知識和資源。例如，Singular Genomics Systems Inc.於2022年1月與Lexogen合作，展示了其G4定序平台與Lexogen RNA研究產品的兼容性。此次合作旨在幫助客戶將G4無縫整合到其現有的下一代定序(NGS)工作流程中。

參與 RNA 分析和轉錄組學市場的主要企業包括 Affymetrix Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、GE Healthcare、Illumina Inc.、QIAGEN NV、F. Hoffmann-La Roche Ltd.、Sigma-Aldrich Corporation、Thermo Fisher Scient Inc.、Fluxic Corporation Inc. SE、Merck KGaA、Pacific Biosciences of California Inc.、Danaher Corporation、Genewiz Inc.、Oxford Nanopore Technologies Ltd.、BGI Group 和 Genotypic Technology Pvt。 Ltd、Ltd.、MedGenome Labs Pvt.Ltd.、Xcelris Labs Ltd.、Ocimum Biosolutions Ltd.、Strand Life Sciences Pvt.Ltd.、SciGenom Labs Pvt.Ltd.、Oncocyte Corporation、Tempus Labs Inc.、ArcherDX Inc. 和 HTG Molec.

2024年，北美是RNA分析和轉錄組學市場最大的地區，預計在預測期內將成為成長最快的地區。 RNA分析和轉錄組學市場報告涵蓋以下地區：亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

RNA 分析和轉錄組學市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

RNA分析和轉錄組學市場涵蓋提供全基因組定序、全外EXOME定序、標靶定序、微陣列分析和桑格定序等服務的營業單位所產生的收益。市場規模包括服務供應商銷售或包含在其服務產品中的相關商品的價值。僅包括企業之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球 RNA 分析和轉錄組學：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球 RNA 分析與轉錄組學市場：成長率分析
  • 全球 RNA 分析與轉錄組學市場表現：規模與成長，2019-2024 年
  • 全球 RNA 分析與轉錄組學市場預測：規模與成長，2024-2029 年，2034 年
  • 全球 RNA 分析與轉錄組學：總潛在市場 (TAM)

第6章 市場細分

  • 全球 RNA 分析和轉錄組學市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 試劑和耗材
  • 裝置
  • 軟體
  • 全球 RNA 分析和轉錄組學市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 微陣列
  • 順序
  • 聚合酵素鏈鎖反應/ RNA干擾
  • 全球 RNA 分析和轉錄組學市場的應用、表現和預測（2019-2024 年、2024-2029 年、2034 年）
  • 臨床診斷
  • 藥物研發
  • 毒理基因組學
  • 比較轉錄組學
  • RNA干擾
  • 全球 RNA 分析和轉錄組學市場：試劑和耗材細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 核苷酸
  • 酵素
  • 緩衝液和溶液
  • 樣品製備套件
  • 定序試劑套件
  • 全球 RNA 分析和轉錄組學市場：儀器細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 序列器
  • 即時PCR設備
  • 微陣列
  • 電泳系統
  • 機器人液體處理器
  • 全球 RNA 分析與轉錄組學市場：軟體細分、類型、表現和預測（2019-2024 年、2024-2029 年、2034 年）
  • 數據分析軟體
  • 生物資訊學工具
  • 統計分析軟體
  • 視覺化軟體
  • 資料庫管理系統

第7章 區域和國家分析

  • 全球 RNA 分析與轉錄組學市場：區域表現與預測（2019-2024 年、2024-2029 年和 2034 年）
  • 全球 RNA 分析與轉錄組學市場：按國家、地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • RNA分析與轉錄組學市場：競爭格局
  • RNA分析與轉錄組學市場：公司簡介
    • Affymetrix Inc.
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • GE Healthcare
    • Illumina Inc.

第31章：其他領先和創新企業

  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Fluidigm Corporation
  • Promega Corporation
  • bioMerieux SA
  • CD Genomics Inc.
  • Eurofins Scientific SE
  • Merck KGaA
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Genewiz Inc.
  • Oxford Nanopore Technologies Ltd.
  • BGI Group

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年 RNA 分析與轉錄組學市場：提供新機會的國家
  • 2029 年 RNA 分析與轉錄組學市場：細分領域將帶來新機會
  • RNA分析與轉錄組學市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22038u

Transcriptomics, also known as RNA analysis, is the study of the transcriptome under specific circumstances, environmental conditions, or within specific cells using high-throughput methods.

The main product categories in the RNA analysis/transcriptomics market include reagents/consumables, instruments, and software. These products find applications in various fields, such as clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference. The major technologies involved in RNA analysis/transcriptomics are microarrays, sequencing, polymerase chain reaction, and RNA interference. In clinical diagnostics, RNA analysis is employed to detect different RNA species, pathogen RNA, splice variants, and other elements crucial for disease diagnosis.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The RNA analysis/ transcriptomics market research report is one of a series of new reports from The Business Research Company that provides RNA analysis/ transcriptomics market statistics, including RNA analysis/ transcriptomics industry global market size, regional shares, competitors with a RNA analysis/ transcriptomics market share, detailed RNA analysis/ transcriptomics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA analysis/ transcriptomics industry. This RNA analysis/ transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rna analysis/ transcriptomics market size has grown rapidly in recent years. It will grow from $7.72 billion in 2024 to $8.74 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to cancer research and precision medicine, drug discovery and development, infectious disease diagnostics, personalized medicine, academic and government funding, growing applications in agriculture.

The rna analysis/ transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $16.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to single-cell rna sequencing applications, integration of rna analysis in clinical diagnostics, rna-basedTherapies and vaccines, bioinformatics and data analysis tools, biomarker discovery and validation. Major trends in the forecast period include spatial transcriptomics and in situ rna analysis, long-read rna sequencing technologies, rna editing and modification analysis, integration of ai in rna data analysis, rna therapeutics for rare diseases, rna-based liquid biopsy for cancer detection.

The forecast of 16.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on reverse transcriptase enzymes and next-generation sequencing flow cells, largely sourced from Switzerland and Singapore, raising expenses for genomic research and diagnostics.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the RNA analysis/transcriptomics market is anticipated to be driven by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical treatment to the unique characteristics of each patient. The RNA-Seq technology is well-suited to manage the substantial clinical workload associated with implementing personalized clinical care practices and processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines available for various conditions such as multiple types of cancer, genetic rare diseases, and chronic and infectious diseases. This surge in demand for personalized medicines is a key factor propelling the growth of the RNA analysis market.

The growing prevalence of chronic diseases is expected to drive the expansion of the RNA analysis/transcriptomics market in the future. Chronic diseases are defined as conditions lasting a year or longer that hinder daily activities and necessitate ongoing medical care. The use of RNA analysis and transcriptomics in chronic disease research enhances understanding of disease mechanisms, leads to better diagnostics, and facilitates the development of more targeted and personalized therapeutic interventions. For instance, in September 2022, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths each year, accounting for 74% of deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur globally. Among these, there were 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising incidence of chronic diseases is propelling the growth of the RNA analysis/transcriptomics market.

An emerging trend in the RNA analysis/transcriptomics market is the focus on technological advancements and innovations in RNA analysis. Next-generation sequencing (NGS) and RNA interference (RNAi) are among the technologies contributing to improved precision and accuracy in analyzing transcriptional activity. Illumina's development of Next-generation sequencing, for example, has proven successful in fragmenting DNA/RNA, sequencing libraries, and reassembling them, enhancing genomic sequence analysis.

Major companies in the RNA analysis/transcriptomics market are increasingly emphasizing the introduction of innovative portfolios to gain a competitive advantage. Twist Bioscience Corporation, in May 2023, launched a comprehensive RNA sequencing tools portfolio, including specific target enrichment capabilities for RNA and whole transcriptome sequencing. The portfolio comprises products such as the Twist RNA Exome, Twist RNA Library Prep Kit, and Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit, offering complete workflows for analyzing mRNA protein coding sequences, custom targets, and total RNA.

Strategic partnerships and collaborations are a significant focus for major companies in the RNA analysis/transcriptomics market. These partnerships often involve integrating expertise in RNA library preparation kits, combining the knowledge and resources of different organizations. For instance, Singular Genomics Systems Inc. collaborated with Lexogen in January 2022 to demonstrate the compatibility of the G4 sequencing platform with Lexogen's products for RNA research. This partnership aims to provide customers with a seamless integration of the G4 into existing Next-Generation Sequencing (NGS) workflows.

Major companies operating in the RNA analysis/ transcriptomics market include Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMerieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

North America was the largest region in the RNA analysis/transcriptomics market in 2024. This region is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA analysis/ transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the RNA analysis/ transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The RNA analysis/ transcriptomics market includes revenues earned by entities by providing services such as Whole-Genome Sequencing, Whole-Exome Sequencing, Targeted Sequencing, Microarray Analysis, Sanger Sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

RNA Analysis/ Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rna analysis/ transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rna analysis/ transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rna analysis/ transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents/Consumables; Instruments; Software

2) By Technology; Microarrays; Sequencing; Polymerase Chain Reaction RNA Interference

  • 3) By Application: Clinical Diagnostics; Drug Discovery; Toxicogenomics; Comparative Transcriptomics; RNA Interference
  • Subsegments:
  • 1) By Reagents/Consumables: Nucleotides; Enzymes; Buffers and Solutions; Sample Preparation Kits; Sequencing Kits
  • 2) By Instruments: Sequencers; Real-Time PCR Machines; Microarrays; Electrophoresis Systems; Robotic Liquid Handlers
  • 3) By Software: Data Analysis Software; Bioinformatics Tools; Statistical Analysis Software; Visualization Software; Database Management Systems
  • Companies Mentioned: Affymetrix Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; GE Healthcare; Illumina Inc.; QIAGEN N.V.; F. Hoffmann-La Roche Ltd.; Sigma-Aldrich Corporation; Thermo Fisher Scientific Inc.; Fluidigm Corporation; Promega Corporation; bioMerieux S.A.; CD Genomics Inc.; Eurofins Scientific SE; Merck KGaA; Pacific Biosciences of California Inc.; Danaher Corporation; Genewiz Inc.; Oxford Nanopore Technologies Ltd.; BGI Group; Genotypic Technology Pvt. Ltd.; MedGenome Labs Pvt. Ltd.; Xcelris Labs Ltd.; Ocimum Biosolutions Ltd.; Strand Life Sciences Pvt. Ltd.; SciGenom Labs Pvt. Ltd.; Oncocyte Corporation; Tempus Labs Inc.; ArcherDX Inc.; HTG Molecular Diagnostics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. RNA Analysis/ Transcriptomics Market Characteristics

3. RNA Analysis/ Transcriptomics Market Trends And Strategies

4. RNA Analysis/ Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global RNA Analysis/ Transcriptomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global RNA Analysis/ Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global RNA Analysis/ Transcriptomics Market Growth Rate Analysis
  • 5.4. Global RNA Analysis/ Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global RNA Analysis/ Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global RNA Analysis/ Transcriptomics Total Addressable Market (TAM)

6. RNA Analysis/ Transcriptomics Market Segmentation

  • 6.1. Global RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents/Consumables
  • Instruments
  • Software
  • 6.2. Global RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarrays
  • Sequencing
  • Polymerase Chain Reaction RNA Interference
  • 6.3. Global RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Diagnostics
  • Drug Discovery
  • Toxicogenomics
  • Comparative Transcriptomics
  • RNA Interference
  • 6.4. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Reagents/Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleotides
  • Enzymes
  • Buffers and Solutions
  • Sample Preparation Kits
  • Sequencing Kits
  • 6.5. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencers
  • Real-Time PCR Machines
  • Microarrays
  • Electrophoresis Systems
  • Robotic Liquid Handlers
  • 6.6. Global RNA Analysis/ Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Bioinformatics Tools
  • Statistical Analysis Software
  • Visualization Software
  • Database Management Systems

7. RNA Analysis/ Transcriptomics Market Regional And Country Analysis

  • 7.1. Global RNA Analysis/ Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global RNA Analysis/ Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific RNA Analysis/ Transcriptomics Market

  • 8.1. Asia-Pacific RNA Analysis/ Transcriptomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China RNA Analysis/ Transcriptomics Market

  • 9.1. China RNA Analysis/ Transcriptomics Market Overview
  • 9.2. China RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India RNA Analysis/ Transcriptomics Market

  • 10.1. India RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan RNA Analysis/ Transcriptomics Market

  • 11.1. Japan RNA Analysis/ Transcriptomics Market Overview
  • 11.2. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia RNA Analysis/ Transcriptomics Market

  • 12.1. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia RNA Analysis/ Transcriptomics Market

  • 13.1. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea RNA Analysis/ Transcriptomics Market

  • 14.1. South Korea RNA Analysis/ Transcriptomics Market Overview
  • 14.2. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe RNA Analysis/ Transcriptomics Market

  • 15.1. Western Europe RNA Analysis/ Transcriptomics Market Overview
  • 15.2. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK RNA Analysis/ Transcriptomics Market

  • 16.1. UK RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany RNA Analysis/ Transcriptomics Market

  • 17.1. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France RNA Analysis/ Transcriptomics Market

  • 18.1. France RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy RNA Analysis/ Transcriptomics Market

  • 19.1. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain RNA Analysis/ Transcriptomics Market

  • 20.1. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe RNA Analysis/ Transcriptomics Market

  • 21.1. Eastern Europe RNA Analysis/ Transcriptomics Market Overview
  • 21.2. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia RNA Analysis/ Transcriptomics Market

  • 22.1. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America RNA Analysis/ Transcriptomics Market

  • 23.1. North America RNA Analysis/ Transcriptomics Market Overview
  • 23.2. North America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA RNA Analysis/ Transcriptomics Market

  • 24.1. USA RNA Analysis/ Transcriptomics Market Overview
  • 24.2. USA RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada RNA Analysis/ Transcriptomics Market

  • 25.1. Canada RNA Analysis/ Transcriptomics Market Overview
  • 25.2. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America RNA Analysis/ Transcriptomics Market

  • 26.1. South America RNA Analysis/ Transcriptomics Market Overview
  • 26.2. South America RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil RNA Analysis/ Transcriptomics Market

  • 27.1. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East RNA Analysis/ Transcriptomics Market

  • 28.1. Middle East RNA Analysis/ Transcriptomics Market Overview
  • 28.2. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa RNA Analysis/ Transcriptomics Market

  • 29.1. Africa RNA Analysis/ Transcriptomics Market Overview
  • 29.2. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa RNA Analysis/ Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. RNA Analysis/ Transcriptomics Market Competitive Landscape And Company Profiles

  • 30.1. RNA Analysis/ Transcriptomics Market Competitive Landscape
  • 30.2. RNA Analysis/ Transcriptomics Market Company Profiles
    • 30.2.1. Affymetrix Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. RNA Analysis/ Transcriptomics Market Other Major And Innovative Companies

  • 31.1. QIAGEN N.V.
  • 31.2. F. Hoffmann-La Roche Ltd.
  • 31.3. Sigma-Aldrich Corporation
  • 31.4. Thermo Fisher Scientific Inc.
  • 31.5. Fluidigm Corporation
  • 31.6. Promega Corporation
  • 31.7. bioMerieux S.A.
  • 31.8. CD Genomics Inc.
  • 31.9. Eurofins Scientific SE
  • 31.10. Merck KGaA
  • 31.11. Pacific Biosciences of California Inc.
  • 31.12. Danaher Corporation
  • 31.13. Genewiz Inc.
  • 31.14. Oxford Nanopore Technologies Ltd.
  • 31.15. BGI Group

32. Global RNA Analysis/ Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market

34. Recent Developments In The RNA Analysis/ Transcriptomics Market

35. RNA Analysis/ Transcriptomics Market High Potential Countries, Segments and Strategies

  • 35.1 RNA Analysis/ Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 RNA Analysis/ Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 RNA Analysis/ Transcriptomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer